Grant: Engage Grants Program
University of British Columbia
$25,000.00
Design and engineering of novel cell permeable proteins that can enter human cells and activate latent HIV-1 provirus
FY 2012-13
Summary
iProgen Biotech and Dr. Ivan Sadowski will collaborate on the engineering and development of novel cell
permeable proteins that can potentially activate latent retroviruses. Such technology would prove to be very
useful in treating various chronic latent viral infections such as HIV, Hepatitis and Herpes. iProgen will apply
its expertise and advanced knowledge in intracellular protein delivery technology to design, engineer and
produce cell permeable proteins with commercial potential. Dr. Sadowski, with expertise in epigenetics, and in
studying mechanism of activating latent viral population, will assist in target selection and validation of the cell
permeable proteins.
Program
Engage Grants Program
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
433741-2012
Name nom
Sadowski, Ivan
Department département
Biochemistry and Molecular Biology
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2012
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1554
Committee name en
Pacific Internal Decision Committee
Committee name fr
Comité de décision interne pour le Pacifique
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
5403
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Proteins and peptides, amino acids
Research subject fr
Protéines et peptides, acides aminés
Partie
1
Nb partie
1
Application title
Design and engineering of novel cell permeable proteins that can enter human cells and activate latent HIV-1 provirus
Keyword
NSERC
Application summary
iProgen Biotech and Dr. Ivan Sadowski will collaborate on the engineering and development of novel cell
permeable proteins that can potentially activate latent retroviruses. Such technology would prove to be very
useful in treating various chronic latent viral infections such as HIV, Hepatitis and Herpes. iProgen will apply
its expertise and advanced knowledge in intracellular protein delivery technology to design, engineer and
produce cell permeable proteins with commercial potential. Dr. Sadowski, with expertise in epigenetics, and in
studying mechanism of activating latent viral population, will assist in target selection and validation of the cell
permeable proteins.